From 1959 through to May, 1993, 363 patients with adenocarcinoma of uterine cervix were initially treated which accounted for 2.5% of all initially treated cases with cervical carcinoma. Patients' mean age was 50.5 years. 46% of the cases were post-menopausal. The main symptom was irregular vaginal bleeding and/or discharge. Over 88% of the cases were in stage II and II! of the disease, they were treated with radiotherapy alone. The overall 5-years survival rate was 51.8%. The recurrence rate Was 17.4% with a mean time to recurrence of 33.3 months Thirteen patients recurred beyond 5 years. Recurrence wasaccompanied with lung metastasis in 17 patients and supraclavicular lymph node metastasis in I I. Among patients whose tumor recurred the 1- and 2- year survival rate were 35.2% and 19.2% respectively. The most significant prognostic factors were the stage of disease, the size of the tumor and the histologic subtypes.